<span item_type="fundamental" item_id="5dcfda9cb7fc2f40a8958999e8899ec7" counter_id="ST/US/IXQUF" env="prod"></span><span item_type="announcement" item_id="534069084071727617" env="prod"></span><p>EPS: As of FY2025 Q1, the actual value is USD 0.03.</p><p></p><h3>Segment Revenue</h3><ul><li>The company has not commenced any operations as of March 31, 2025, and all activity relates to the company’s formation and the search for a prospective initial Business Combination.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li></ul><h3>Operational Metrics</h3><ul><li>Net income for the three months ended March 31, 2025, was $242,125, compared to a net loss of $721,742 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li><li>Operating and formation expenses decreased to $281,488 for the three months ended March 31, 2025, from $880,791 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li></ul><h3>Cash Flow</h3><ul><li>Net cash used in operating activities was $240,778 for the three months ended March 31, 2025, compared to $308,403 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li><li>Cash provided by financing activities was $385,934 for the three months ended March 31, 2025, compared to $441,000 for the same period in 2024.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li></ul><h3>Unique Metrics</h3><ul><li>The company has a working capital deficit of approximately $6.9 million as of March 31, 2025.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li></ul><h3>Future Outlook and Strategy</h3><ul><li><strong>Core Business Focus</strong>: The company plans to consummate its initial Business Combination by October 12, 2025, if all extensions are exercised. The management is focused on addressing liquidity conditions and mandatory liquidation risks should a Business Combination not occur.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li><li><strong>Non-Core Business</strong>: The company has entered into a Merger Agreement with AERKOMM Inc. and is working on securing PIPE investments and SAFE agreements to support the merger.<span class="superscript" item_id="0" item_type="announcement_file" value="1" url="https://www.sec.gov/Archives/edgar/data/1852019/000141057825001434/ixaqu-20250331x10q.htm"></span></li></ul>

IX ACQUISITION CORP UNIT 1 CL A & 1/2 WT EXP (31/07/2028) | 10-Q: FY2025 Q1 EPS: USD 0.03